Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
CHGCF Quote, Financials, Valuation and Earnings
Last price:
$55.44
Seasonality move
:
0.48%
Day range:
$50.98 - $55.44
52-week range:
$32.25 - $72.30
Dividend yield:
1.27%
P/E ratio:
34.23x
P/S ratio:
11.21x
P/B ratio:
7.13x
Volume:
874
Avg. volume:
2.2K
1-year change:
32.79%
Market cap:
$91.2B
Revenue:
$7.7B
EPS (TTM):
$1.62
Earnings Data
Next earnings date for CHGCF
Jan 29
2026
Most recent earnings per share
$0.46
Beat by $0.46
(Oct 24/2025)
Consensus Estimate
--
(Oct 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CHGCF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/24/2025 | Q3 | -- | $2.3B | $0.46 | -- | -- |
| 06/30/2025 | Q2 | -- | $2B | $0.41 | -- | -- |
| 04/24/2025 | Q1 | -- | $1.9B | $0.39 | -- | -- |
| 12/31/2024 | Q4 | -- | $2B | $0.37 | -- | -- |
| 10/25/2024 | Q3 | -- | $2.1B | $0.45 | -- | -- |
| 07/25/2024 | Q2 | -- | $2B | $0.44 | -- | -- |
| 04/24/2024 | Q1 | -- | $1.6B | $0.30 | -- | -- |
| 02/01/2024 | Q4 | -- | $1.9B | $0.37 | -- | -- |
| 09/30/2023 | Q3 | -- | $1.8B | $0.33 | -- | -- |
| 07/27/2023 | Q2 | -- | $1.9B | $0.37 | -- | -- |
| 04/27/2023 | Q1 | -- | $2.4B | $0.34 | -- | -- |
| 12/31/2022 | Q4 | -- | $3.1B | $0.44 | -- | -- |
| 10/24/2022 | Q3 | -- | $1.6B | $0.30 | -- | -- |
| 07/21/2022 | Q2 | -- | $1.8B | $0.34 | -- | -- |
| 04/25/2022 | Q1 | -- | $2.3B | $0.69 | -- | -- |
| 02/03/2022 | Q4 | -- | $2.8B | $0.53 | -- | -- |
| 10/22/2021 | Q3 | -- | $2.6B | $0.47 | -- | -- |
| 07/26/2021 | Q2 | -- | $2B | $0.39 | -- | -- |
| 04/22/2021 | Q1 | -- | $1.6B | $0.27 | -- | -- |
| 02/04/2021 | Q4 | -- | $2B | $0.30 | -- | -- |
| 10/22/2020 | Q3 | -- | $2B | $0.34 | -- | -- |
| 07/27/2020 | Q2 | -- | $1.8B | $0.29 | -- | -- |
| 04/23/2020 | Q1 | -- | $1.6B | $0.29 | -- | -- |
| 01/30/2020 | Q4 | -- | $1.6B | $0.22 | -- | -- |
| 10/24/2019 | Q3 | -- | $1.8B | $0.27 | -- | -- |
| 07/25/2019 | Q2 | -- | $1.5B | $0.19 | -- | -- |
| 04/24/2019 | Q1 | -- | $1.4B | $0.19 | -- | -- |
| 01/31/2019 | Q4 | -- | $1.4B | $0.12 | -- | -- |
| 10/24/2018 | Q3 | -- | $1.3B | $0.12 | -- | -- |
| 07/26/2018 | Q2 | -- | $1.3B | $0.12 | -- | -- |
| 04/24/2018 | Q1 | -- | $1.4B | $0.16 | -- | -- |
| 02/01/2018 | Q4 | -- | $1.3B | $0.08 | -- | -- |
| 10/25/2017 | Q3 | -- | $1.2B | $0.12 | -- | -- |
| 07/27/2017 | Q2 | -- | $1.1B | $0.10 | -- | -- |
| 04/25/2017 | Q1 | -- | $1.1B | $0.10 | -- | -- |
| 02/01/2017 | Q4 | -- | $1.2B | $0.06 | -- | -- |
| 10/25/2016 | Q3 | -- | $1.1B | $0.07 | -- | -- |
| 07/21/2016 | Q2 | -- | $1.2B | $0.10 | -- | -- |
| 03/31/2016 | Q1 | -- | $1B | $0.08 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.1B | $0.07 | -- | -- |
Chugai Pharmaceutical Co., Ltd. Earnings Questions
-
How Much did Chugai Pharmaceutical Co., Ltd. Generate in Revenue Last Quarter?
Chugai Pharmaceutical Co., Ltd. reported $2.3B worth of top line sales in its most recent quarter.
-
Did Chugai Pharmaceutical Co., Ltd. Beat Earnings Last Quarter?
Chugai Pharmaceutical Co., Ltd. announced earnings per share of $0.46 which represents a beat of analyst forecast a -- per share.
-
Is Chugai Pharmaceutical Co., Ltd. Profitable?
Chugai Pharmaceutical Co., Ltd. reported $1.6B that represents $0.96 per share over the last quarter.
-
What is the Analyst Consensus for Chugai Pharmaceutical Co., Ltd. EPS Next Year?
Chugai Pharmaceutical Co., Ltd.'s earnings are forecast to grow from $1.55 per share to -- per share next year representing an increase of --.
-
When is Chugai Pharmaceutical Co., Ltd.'s Earnings Date?
Chugai Pharmaceutical Co., Ltd.'s next earnings date is January 29, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
